Clinical Trials on Anomalies Vascular in Australia

Total 1960 results

Murdoch Childrens Research Institute
Royal Children's Hospital; Peter MacCallum Cancer Centre, Australia

Not yet recruiting

A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations (TARGET-VM)

Arteriovenous Malformations | Vascular Malformations | MAP2K1 Gene Mutation | PIK3CA-related Overgrowth Spectrum | Vascular Anomalies | Lymphangioma | Lymphatic Malformation | KRAS G12D | Venous Malformation | Vascular Anomaly | KRAS G12C | PI3K Gene Mutation | Slow-Flow Vascular Malformation | Fast-Flow Vascular... and other conditions

Australia
University of Sydney
Allergan

Completed

Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema (SwitchDMO)

Diabetes | Diabetic Retinopathy | Diabetic Macular Edema | Diabetic Macular Oedema

Australia
Alucent Biomedical

Active, not recruiting

Feasibility Study of the Vessel Restoration System (VRS): ACTIVATE II (ACTIVATEII)

PAD - Peripheral Arterial Disease

Australia
Flinders University
The Queen Elizabeth Hospital; Flinders Medical Centre; Royal Adelaide Hospital

Completed

Effect of Exercise Training on Protein Expression in Skeletal Muscle Tissue After Exercise in Peripheral Arterial Disease

Peripheral Arterial Disease

Australia
Monash University
Monash Health

Recruiting

Carnosine for Peripheral Vascular Disease (Car-PVD)

Peripheral Arterial Disease

Australia
Biotronik CRC Inc.
Biotronik AG

Active, not recruiting

BRight DCB First-in-Human Study

Peripheral Artery Disease

New Zealand, Australia, Germany, Austria
SCAD Alliance
PERFUSE Study Group

Recruiting

International Spontaneous Coronary Artery Dissection (SCAD) "iSCAD" Registry

Spontaneous Coronary Artery Dissection

United States, Australia
Alucent Biomedical

Active, not recruiting

Feasibility Study of the Vessel Restoration System (VRS) for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (SFA) and/or Popliteal Artery (PA) After Sub-optimal Percutaneous Transluminal Angioplasty (PTA) or Atherectomy: REACTIVATE I (REACTIVATE I)

PAD - Peripheral Arterial Disease

Australia
University of Sydney
National Health and Medical Research Council, Australia

Completed

Intravitreal Bevacizumab (Avastin®) Versus Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema

Diabetic Retinopathy | Macular Edema

Australia
University of Adelaide

Unknown

Effects of Renal Sympathetic Denervation on the Cardiac and Renal Functions in Patients With Drug-resistant Hypertension Through MRI Evaluation (RDN)

Uncontrolled Hypertension

Australia
Royal Perth Hospital

Recruiting

Neuroinflammation in Hypertension Study (MINIHT)

Resistant Hypertension

Australia
ADARx Pharmaceuticals, Inc.
ADARx Australia Pty Ltd

Recruiting

Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension

Hypertension | Hypertension,Essential

Australia
University of Sydney

Recruiting

Near-Infrared Light Photobiomodulation Treatment for Retinal Vein Occlusion Macular Oedema (NIRVO)

Retinal Vein Occlusion | Macula Edema

Australia
Novartis Pharmaceuticals

Recruiting

Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR) (REPLENISH-EXT)

Polymyalgia Rheumatica

Australia
Biotronik AG

Active, not recruiting

BIO REsponse Adapted Combination Therapy Pilot Study

Peripheral Arterial Disease

Australia, Belgium, France, Germany, Austria, Spain
480 Biomedical

Completed

480 Biomedical Bioresorbable Scaffold System in the Treatment of de Novo Superficial Femoral Artery (SFA) Lesions (STANCE)

Atherosclerosis of Femoral Artery | Superficial Femoral Artery Lesions

New Zealand, Austria, Australia, Germany
Augenabteilung Allgemeines Krankenhaus Linz

Completed

Effect Aflibercept on Ocular Perfusion

Macular Degeneration | Anti Vascular Endothelial Growth Factor

Austria
Royal Brisbane and Women's Hospital

Unknown

Peripheral Venous Catheter Trial: 3 Day Versus No Routine Change

Phlebitis

Australia
Ripple Therapeutics Pty Ltd
Novotech (Australia) Pty Limited

Active, not recruiting

Safety and Efficacy of IBE-814 Intravitreal (IVT) Implant - A Sustained, Low Dose Dexamethasone Therapy

Diabetic Macular Oedema | Retinal Vein Occlusion With Macular Oedema

Australia, New Zealand, Hong Kong, Canada
Medical University of Vienna

Terminated

The Effect of a Single Intravitreal Anti-VEGF Therapy on Optic Nerve Head Perfusion

Macular Degeneration | Vascular Endothelial Growth Factor | Regional Blood Flow

Austria
Lions Eye Institute, Perth, Western Australia
Allergan; Lions Outback Vision

Completed

Intravitreal Dexamethasone vs Bevacizumab in Aboriginal People With DMO (OASIS)

Diabetic Retinopathy | Diabetic Macular Edema

Australia
SurModics, Inc.

Completed

Safety and Feasibility of Surmodics SUNDANCE™ Drug Coated Balloon (SWING)

Peripheral Arterial Disease | Critical Lower Limb Ischemia

New Zealand, Australia, Austria, Germany, Latvia
InnoVein

Recruiting

Feasibility of the InnoVein Valve and Delivery System for Chronic Venous Insufficiency

Chronic Venous Insufficiency

Australia
Neurotech Pharmaceuticals

Completed

Extension Study of NT-501 Ciliary Neurotrophic Factor (CNTF) Implant for Macular Telangiectasia (MacTel)

Macular Telangiectasia

United States, Australia
Bayside Health

Completed

Angiotensin Converting Enzyme (ACE) Inhibition and Peripheral Arterial Disease

Peripheral Arterial Disease

Australia
Baker Heart Research Institute

Completed

The Effects of Ramipril on Clinical Symptoms in Patients With Peripheral Arterial Disease

Peripheral Arterial Disease

Australia
Bayside Health
National Health and Medical Research Council, Australia

Terminated

Effects of Niacin on Good Cholesterol in People With Peripheral Arterial Disease

Peripheral Arterial Disease

Australia
Abbott Medical Devices

Completed

Safety and Efficacy Study of Renal Artery Ablation in Resistant Hypertension Patients (EnligHTN-I)

Hypertension

Australia, Greece
Amplitude Vascular Systems, Inc.

Active, not recruiting

POWER: Pulse Intravascular Lithotripsy (Pulse IVL) to Open Vessels With Calcific Walls and Enhance Vascular Compliance and Remodeling (POWER-PAD-1)

Peripheral Arterial Disease

Australia, New Zealand, Dominican Republic
Curtin University

Completed

The Fall Monty Activity Programme Feasibility Study (FallMAP)

Stroke

Australia
Prim. Prof. Dr. Oliver Findl, MBA

Recruiting

Computer-based Tutorial and Automated Speech Recognition for Intravitreal Drug Injections

Age-related Macular Degeneration | Diabetic Macular Edema | Retinal Vein Occlusion

Austria
Foundation for Cardiovascular Research, Zurich
Abbott Medical Devices

Unknown

PC-Trial: Patent Foramen Ovale and Cryptogenic Embolism

Heart Septal Defects, Atrial | Embolism, Paradoxical

Australia, Austria, Belgium, Switzerland
Biotronik CRC Inc.

Not yet recruiting

BRight Pharmacokinetic Study

Peripheral Artery Disease

Australia
Bilix Co.,Ltd.

Recruiting

A Study to Evaluate the Safety and Pharmacokinetics of BX-001N in Healthy Participants

Ischemia-reperfusion Injury

Australia
Neurotech Pharmaceuticals
The Lowy Medical Research Institute Limited

Completed

Safety Study to Evaluate Bilateral CNTF Implants in Subjects With MacTel Type 2

Macular Telangiectasia Type 2

United States, Australia
Nexel Co., Ltd.
Novotech (Australia) Pty Limited

Completed

A Study of NP-011 in Healthy Volunteers

Myocardial Infarction

Australia
ADARx Pharmaceuticals, Inc.

Recruiting

Safety, Tolerability, PK, PD of ADX-324 in Healthy Volunteers and Hereditary Angioedema Patients

Hereditary Angioedema

Australia
Boston Scientific Corporation

Completed

Stenting of the Superficial Femoral and/or Proximal Popliteal Artery Project (MAJESTIC)

Atherosclerosis of Native Arteries of the Extremities

New Zealand, Germany, Belgium, Australia, Austria
Royal Perth Hospital
The University of Western Australia

Recruiting

Sympathoinhibition as a Preferred Second Line Treatment of Obesity Related Hypertension (OHT)

Hypertension | Obesity

Australia
Symic Vascular
Symic Biomedical, Inc.

Unknown

Angioplasty + SBCV vs. Angioplasty Alone for Femoropopliteal Artery Stenosis (SHIELD)

Peripheral Arterial Disease

Australia, New Zealand
Ji Xing Pharmaceuticals Australia Pty Ltd
Novotech (Australia) Pty Limited

Recruiting

JX09 SAD/MAD in Healthy Participants

Resistant Hypertension

Australia
Infraredx
Royal Adelaide Hospital; South Australian Health and Medical Research Institute

Completed

In Vitro and In Vivo Comparison Between Intravascular Ultrasound (IVUS) Systems (SAVOIR2)

Coronary Artery Disease

Australia
Melbourne Health

Completed

Attenuation of Cardiac Effects of Arteriovenous Fistula Creation With Losartan

Renal Failure | Left Ventricular Hypertrophy

Australia
Kona Medical Inc.

Completed

A Safety Evaluation of Renal Denervation Using Focused Therapeutic Ultrasound on Patients With Refractory Hypertension

Hypertension

Australia
Cibiem, Inc.

Unknown

First-In-Human Study Evaluating a Novel Catheter Device in Subjects With Treatment-Resistant Hypertension

Hypertension,Essential

Australia, Czechia, Germany
Baker Heart and Diabetes Institute

Completed

Sham Controlled Clinical Trial of Renal Denervation in Patients With Resistant Hypertension

Hypertension

Australia
Baker Heart and Diabetes Institute

Terminated

Renal Denervation for Resistant Hypertension (RDNP-2012-01)

Hypertension

Australia
Gmax Biopharm Australia Pty Ltd.
Metaclinical; Syneos Heath

Completed

A Study to Investigate Safe and Tolerable Dose of GMA301 Injection in Healthy Volunteers

Pulmonary Arterial Hypertension

Australia
Allergan

Completed

A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion

Macular Edema | Retinal Vein Occlusion

France, United States, Canada, Taiwan, Australia, Austria, Czechia, Portugal, Germany, Israel, Philippines, Mexico, South Africa
Curtin University

Active, not recruiting

Long-term Use of CCB and Breast Cancer Risk

Breast Cancer | Hypertension,Essential

Australia

Clinical Trials on Anomalies Vascular in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Suriname

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations